Annual EBITDA:
$49.90M+$23.80M(+91.20%)Summary
- As of today, TGTX annual EBITDA is $49.90 million, with the most recent change of +$23.80 million (+91.20%) on December 31, 2024.
- During the last 3 years, TGTX annual EBITDA has risen by +$391.87 million (+114.59%).
- TGTX annual EBITDA is now at all-time high.
Performance
TGTX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
$29.43M-$5.47M(-15.69%)Summary
- As of today, TGTX quarterly EBITDA is $29.43 million, with the most recent change of -$5.47 million (-15.69%) on September 30, 2025.
- Over the past year, TGTX quarterly EBITDA has increased by +$16.93 million (+135.45%).
- TGTX quarterly EBITDA is now -74.39% below its all-time high of $114.91 million, reached on September 30, 2023.
Performance
TGTX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$103.02M+$16.93M(+19.66%)Summary
- As of today, TGTX TTM EBITDA is $103.02 million, with the most recent change of +$16.93 million (+19.66%) on September 30, 2025.
- Over the past year, TGTX TTM EBITDA has increased by +$103.21 million (+52660.20%).
- TGTX TTM EBITDA is now at all-time high.
Performance
TGTX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
TGTX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +91.2% | +135.4% | +10000.0% |
| 3Y3 Years | +114.6% | +184.5% | +144.2% |
| 5Y5 Years | +129.8% | +134.4% | +146.2% |
TGTX EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +114.6% | -74.4% | +156.7% | at high | +144.2% |
| 5Y | 5-Year | at high | +114.6% | -74.4% | +131.7% | at high | +129.9% |
| All-Time | All-Time | at high | +114.6% | -74.4% | +131.7% | at high | +129.9% |
TGTX EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2025 | - | $29.43M(-15.7%) | $103.02M(+19.7%) |
| Jun 2025 | - | $34.90M(+302.2%) | $86.09M(+43.3%) |
| Mar 2025 | - | $8.68M(-71.1%) | $60.08M(+42.3%) |
| Dec 2024 | $49.90M(+91.2%) | $30.01M(+140.1%) | $42.21M(>+9900.0%) |
| Sep 2024 | - | $12.50M(+40.6%) | -$196.00K(-100.2%) |
| Jun 2024 | - | $8.89M(+196.7%) | $102.22M(+109.7%) |
| Mar 2024 | - | -$9.19M(+25.9%) | $48.74M(+131.5%) |
| Dec 2023 | $26.10M(+112.2%) | -$12.39M(-110.8%) | $21.06M(+213.9%) |
| Sep 2023 | - | $114.91M(+357.7%) | -$18.49M(+89.0%) |
| Jun 2023 | - | -$44.59M(-20.9%) | -$168.23M(-3.6%) |
| Mar 2023 | - | -$36.87M(+29.0%) | -$162.45M(+15.5%) |
| Dec 2022 | -$213.11M(+37.7%) | -$51.94M(-49.1%) | -$192.32M(+17.5%) |
| Sep 2022 | - | -$34.83M(+10.2%) | -$233.20M(+17.7%) |
| Jun 2022 | - | -$38.81M(+41.9%) | -$283.37M(+12.0%) |
| Mar 2022 | - | -$66.74M(+28.1%) | -$321.93M(+6.5%) |
| Dec 2021 | -$341.97M(-25.4%) | -$92.81M(-9.2%) | -$344.27M(-1.8%) |
| Sep 2021 | - | -$85.00M(-9.9%) | -$338.14M(+0.2%) |
| Jun 2021 | - | -$77.37M(+13.2%) | -$338.76M(-8.5%) |
| Mar 2021 | - | -$89.09M(-2.8%) | -$312.15M(-15.1%) |
| Dec 2020 | -$272.68M(-63.0%) | -$86.68M(-1.2%) | -$271.22M(-21.7%) |
| Sep 2020 | - | -$85.63M(-68.7%) | -$222.93M(-12.5%) |
| Jun 2020 | - | -$50.76M(-5.4%) | -$198.14M(-8.3%) |
| Mar 2020 | - | -$48.16M(-25.5%) | -$182.90M(-8.0%) |
| Dec 2019 | -$167.30M(+2.9%) | -$38.39M(+36.9%) | -$169.41M(+8.5%) |
| Sep 2019 | - | -$60.84M(-71.3%) | -$185.15M(-16.7%) |
| Jun 2019 | - | -$35.52M(-2.5%) | -$158.62M(+5.3%) |
| Mar 2019 | - | -$34.67M(+36.0%) | -$167.42M(+4.0%) |
| Dec 2018 | -$172.38M(-46.8%) | -$54.13M(-57.8%) | -$174.31M(-15.3%) |
| Sep 2018 | - | -$34.30M(+22.6%) | -$151.20M(-1.8%) |
| Jun 2018 | - | -$44.32M(-6.7%) | -$148.46M(-12.0%) |
| Mar 2018 | - | -$41.56M(-34.0%) | -$132.54M(-11.7%) |
| Dec 2017 | -$117.42M(-48.8%) | -$31.01M(+1.7%) | -$118.63M(-6.3%) |
| Sep 2017 | - | -$31.56M(-11.1%) | -$111.62M(-6.3%) |
| Jun 2017 | - | -$28.40M(-2.7%) | -$104.96M(-13.4%) |
| Mar 2017 | - | -$27.65M(-15.2%) | -$92.57M(-17.3%) |
| Dec 2016 | -$78.91M(-24.9%) | -$24.01M(+3.6%) | -$78.91M(-8.8%) |
| Sep 2016 | - | -$24.91M(-55.6%) | -$72.53M(-18.0%) |
| Jun 2016 | - | -$16.01M(-14.4%) | -$61.45M(+1.8%) |
| Mar 2016 | - | -$13.99M(+20.7%) | -$62.55M(+1.0%) |
| Dec 2015 | -$63.16M(-13.4%) | -$17.63M(-27.6%) | -$63.16M(+1.7%) |
| Sep 2015 | - | -$13.82M(+19.2%) | -$64.25M(+5.3%) |
| Jun 2015 | - | -$17.11M(-17.2%) | -$67.87M(-8.2%) |
| Mar 2015 | - | -$14.60M(+22.0%) | -$62.71M(-12.6%) |
| Dec 2014 | -$55.72M(-185.4%) | -$18.72M(-7.3%) | -$55.72M(-32.1%) |
| Sep 2014 | - | -$17.44M(-45.9%) | -$42.18M(-43.5%) |
| Jun 2014 | - | -$11.95M(-57.2%) | -$29.38M(-22.1%) |
| Mar 2014 | - | -$7.60M(-46.9%) | -$24.06M(-19.3%) |
| Dec 2013 | -$19.52M(+21.7%) | -$5.18M(-11.4%) | -$20.17M(-14.7%) |
| Sep 2013 | - | -$4.65M(+29.9%) | -$17.58M(-12.4%) |
| Jun 2013 | - | -$6.63M(-78.5%) | -$15.64M(-73.5%) |
| Mar 2013 | - | -$3.71M(-43.6%) | -$9.01M(+60.3%) |
| Dec 2012 | -$24.95M(-2728.5%) | -$2.59M(+4.7%) | -$22.69M(-12.9%) |
| Sep 2012 | - | -$2.71M(+84.4%) | -$20.10M(-11.9%) |
| Mar 2012 | - | -$17.39M(>-9900.0%) | -$17.97M(-1260.1%) |
| Dec 2011 | -$882.00K(+56.2%) | -$1400.00(+99.5%) | -$1.32M(+25.2%) |
| Sep 2011 | - | -$261.60K(+18.9%) | -$1.77M(+12.6%) |
| Jun 2011 | - | -$322.50K(+56.2%) | -$2.02M(+9.1%) |
| Mar 2011 | - | -$735.80K(-65.1%) | -$2.22M(-10.3%) |
| Dec 2010 | -$2.01M | -$445.80K(+13.5%) | -$2.01M(-5.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2010 | - | -$515.40K(+1.5%) | -$1.91M(-6.8%) |
| Jun 2010 | - | -$523.50K(+1.0%) | -$1.79M(-2.7%) |
| Mar 2010 | - | -$528.60K(-55.4%) | -$1.74M(+1.5%) |
| Dec 2009 | -$1.77M(+59.7%) | -$340.10K(+13.8%) | -$1.77M(-19.7%) |
| Sep 2009 | - | -$394.40K(+17.1%) | -$1.48M(+39.9%) |
| Jun 2009 | - | -$475.80K(+14.4%) | -$2.46M(+28.6%) |
| Mar 2009 | - | -$555.80K(-1025.1%) | -$3.44M(+23.4%) |
| Dec 2008 | -$4.39M(+63.7%) | -$49.40K(+96.4%) | -$4.49M(+29.3%) |
| Sep 2008 | - | -$1.38M(+5.7%) | -$6.35M(+17.2%) |
| Jun 2008 | - | -$1.46M(+9.1%) | -$7.67M(+31.0%) |
| Mar 2008 | - | -$1.61M(+15.9%) | -$11.12M(+8.0%) |
| Dec 2007 | -$12.10M(-21.7%) | -$1.91M(+29.1%) | -$12.10M(+9.4%) |
| Sep 2007 | - | -$2.70M(+45.1%) | -$13.35M(-5.9%) |
| Jun 2007 | - | -$4.91M(-90.4%) | -$12.60M(-25.6%) |
| Mar 2007 | - | -$2.58M(+18.5%) | -$10.04M(+3.1%) |
| Dec 2006 | -$9.94M(+48.5%) | -$3.16M(-62.3%) | -$10.36M(-5.5%) |
| Sep 2006 | - | -$1.95M(+16.7%) | -$9.82M(-1.0%) |
| Jun 2006 | - | -$2.34M(+19.2%) | -$9.72M(-9.5%) |
| Mar 2006 | - | -$2.90M(-10.4%) | -$8.87M(-19.6%) |
| Dec 2005 | -$19.30M(-220.9%) | -$2.63M(-42.1%) | -$7.42M(-12.9%) |
| Sep 2005 | - | -$1.85M(-23.6%) | -$6.57M(+5.5%) |
| Jun 2005 | - | -$1.50M(-3.6%) | -$6.95M(-8.0%) |
| Mar 2005 | - | -$1.44M(+18.9%) | -$6.44M(-5.3%) |
| Dec 2004 | -$6.01M(-31.6%) | -$1.78M(+20.3%) | -$6.12M(-4.5%) |
| Sep 2004 | - | -$2.23M(-127.5%) | -$5.85M(-34.0%) |
| Jun 2004 | - | -$981.80K(+12.3%) | -$4.37M(-7.0%) |
| Mar 2004 | - | -$1.12M(+26.2%) | -$4.08M(-21.6%) |
| Dec 2003 | -$4.57M(-359.0%) | -$1.52M(-102.7%) | -$3.36M(-53.1%) |
| Sep 2003 | - | -$749.10K(-7.6%) | -$2.19M(-8.6%) |
| Jun 2003 | - | -$696.00K(-76.0%) | -$2.02M(-57.8%) |
| Mar 2003 | - | -$395.40K(-11.7%) | -$1.28M(+14.8%) |
| Dec 2002 | -$995.50K(+67.3%) | -$354.00K(+38.5%) | -$1.50M(+11.4%) |
| Sep 2002 | - | -$575.20K(-1401.4%) | -$1.70M(+6.5%) |
| Jun 2002 | - | $44.20K(+107.1%) | -$1.81M(+45.3%) |
| Mar 2002 | - | -$618.40K(-13.1%) | -$3.32M(-13.5%) |
| Dec 2001 | -$3.04M(+1.5%) | -$547.00K(+21.1%) | -$2.92M(-8916.0%) |
| Sep 2001 | - | -$693.40K(+52.4%) | -$32.40K(+88.6%) |
| Jun 2001 | - | -$1.46M(-549.0%) | -$283.60K(+85.1%) |
| Mar 2001 | - | -$224.40K(-109.6%) | -$1.91M(+52.4%) |
| Dec 2000 | -$3.09M(-18.7%) | $2.34M(+347.9%) | -$4.01M(+42.5%) |
| Sep 2000 | - | -$944.60K(+69.3%) | -$6.98M(-8.1%) |
| Jun 2000 | - | -$3.08M(-32.3%) | -$6.46M(-59.4%) |
| Mar 2000 | - | -$2.33M(-271.1%) | -$4.05M(-54.4%) |
| Dec 1999 | -$2.60M(+13.3%) | -$627.40K(-47.9%) | -$2.63M(+38.1%) |
| Sep 1999 | - | -$424.20K(+37.0%) | -$4.24M(+16.7%) |
| Jun 1999 | - | -$672.80K(+25.3%) | -$5.09M(-45.4%) |
| Mar 1999 | - | -$900.90K(+59.9%) | -$3.50M(+11.2%) |
| Dec 1998 | -$3.00M(+42.3%) | -$2.24M(-75.8%) | -$3.95M(-19.5%) |
| Sep 1998 | - | -$1.28M(-239.0%) | -$3.30M(-9.1%) |
| Jun 1998 | - | $918.60K(+168.4%) | -$3.02M(+46.4%) |
| Mar 1998 | - | -$1.34M(+16.1%) | -$5.64M(-10.6%) |
| Dec 1997 | -$5.20M(-40.5%) | -$1.60M(-60.0%) | -$5.10M(-10.9%) |
| Sep 1997 | - | -$1.00M(+41.2%) | -$4.60M(+2.1%) |
| Jun 1997 | - | -$1.70M(-112.5%) | -$4.70M(-30.6%) |
| Mar 1997 | - | -$800.00K(+27.3%) | -$3.60M(-33.3%) |
| Dec 1996 | -$3.70M | -$1.10M(0.0%) | -$2.70M(-68.8%) |
| Sep 1996 | - | -$1.10M(-83.3%) | -$1.60M(-220.0%) |
| Jun 1996 | - | -$600.00K(-700.0%) | -$500.00K(-600.0%) |
| Mar 1996 | - | $100.00K | $100.00K |
FAQ
- What is TG Therapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. annual EBITDA year-on-year change?
- What is TG Therapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. quarterly EBITDA year-on-year change?
- What is TG Therapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for TG Therapeutics, Inc.?
- What is TG Therapeutics, Inc. TTM EBITDA year-on-year change?
What is TG Therapeutics, Inc. annual EBITDA?
The current annual EBITDA of TGTX is $49.90M
What is the all-time high annual EBITDA for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high annual EBITDA is $49.90M
What is TG Therapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, TGTX annual EBITDA has changed by +$23.80M (+91.20%)
What is TG Therapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of TGTX is $29.43M
What is the all-time high quarterly EBITDA for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high quarterly EBITDA is $114.91M
What is TG Therapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, TGTX quarterly EBITDA has changed by +$16.93M (+135.45%)
What is TG Therapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of TGTX is $103.02M
What is the all-time high TTM EBITDA for TG Therapeutics, Inc.?
TG Therapeutics, Inc. all-time high TTM EBITDA is $103.02M
What is TG Therapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, TGTX TTM EBITDA has changed by +$103.21M (+52660.20%)